Healthcare provider profile · identity verified

Timothy Norman Beamesderfer, MD

Internal Medicine · CITRUS HEIGHTS, CA · NPI 1649298704

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	622	186
Levothyroxine Sodium	Levothyroxine Sodium	344	92
Lisinopril	Lisinopril	341	97
Losartan Potassium	Losartan Potassium	312	93
Amlodipine Besylate	Amlodipine Besylate	271	84
Simvastatin	Simvastatin	252	67
Gabapentin	Gabapentin	245	66
Omeprazole	Omeprazole	239	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	235	55
Hydrochlorothiazide	Hydrochlorothiazide	227	63
Pantoprazole Sodium	Pantoprazole Sodium	165	53
Trazodone Hcl	Trazodone Hcl	153	41
Metoprolol Succinate	Metoprolol Succinate	149	44
Metformin Hcl	Metformin Hcl	146	43
Fluticasone Propionate	Fluticasone Propionate	142	48
Albuterol Sulfate Hfa	Albuterol Sulfate	137	58
Metoprolol Tartrate	Metoprolol Tartrate	125	37
Alprazolam	Alprazolam	124	18
Escitalopram Oxalate	Escitalopram Oxalate	119	26
Tamsulosin Hcl	Tamsulosin Hcl	115	41
Rosuvastatin Calcium	Rosuvastatin Calcium	107	33
Montelukast Sodium	Montelukast Sodium	97	24
Duloxetine Hcl	Duloxetine Hcl	94	24
Furosemide	Furosemide	91	31
Eliquis	Apixaban	83	21
Lorazepam	Lorazepam	80	24
Potassium Chloride	Potassium Chloride	80	28
Sertraline Hcl	Sertraline Hcl	74	20
Allopurinol	Allopurinol	73	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	23
Metformin Hcl Er	Metformin Hcl	67	23
Pregabalin	Pregabalin	65	12
Triamcinolone Acetonide	Triamcinolone Acetonide	64	44
Tramadol Hcl	Tramadol Hcl	63	22
Alendronate Sodium	Alendronate Sodium	62	20
Oxycodone Hcl	Oxycodone Hcl	61	15
Ozempic	Semaglutide	60	12
Azelastine Hcl	Azelastine Hcl	57	27
Januvia	Sitagliptin Phosphate	57	12
Jardiance	Empagliflozin	55	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	13
Trulicity	Dulaglutide	55	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Famotidine	Famotidine	53	19
Zolpidem Tartrate	Zolpidem Tartrate	53	18
Estradiol	Estradiol	49	18
Synthroid	Levothyroxine Sodium	48	13
Atenolol	Atenolol	44	11
Rybelsus	Semaglutide	44	13
Spironolactone	Spironolactone	44	14
Bupropion Xl	Bupropion Hcl	43	11
Fluoxetine Hcl	Fluoxetine Hcl	42	11
Lovastatin	Lovastatin	42	13
Clonazepam	Clonazepam	41	11
Mirtazapine	Mirtazapine	38	suppressed
Carvedilol	Carvedilol	37	13
Ibuprofen	Ibuprofen	37	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Celecoxib	Celecoxib	36	13
Buprenorphine	Buprenorphine	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	13
Finasteride	Finasteride	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	31
Nystatin	Nystatin	32	15
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	13
Wixela Inhub	Fluticasone Propion/Salmeterol	32	13
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	11
Acyclovir	Acyclovir	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	15
Fentanyl	Fentanyl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	11
Levetiracetam	Levetiracetam	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Felodipine Er	Felodipine	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	14
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Colchicine	Colchicine	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Glipizide	Glipizide	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Indapamide	Indapamide	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Diazepam	Diazepam	16	11
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Klor-Con 10	Potassium Chloride	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Azithromycin	Azithromycin	13	13
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Felbamate	Felbamate	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Sulindac	Sulindac	12	suppressed
Testosterone	Testosterone	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Percocet	Oxycodone Hcl/Acetaminophen	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error